Clinical Trial Update: Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Cryospray ablation on lung tissue resection specimens to assess safety and histological effects; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: CSA Medical, Inc. | Conditions: Lung Cancer | Phase 4 | Status: COMPLETED